RP
PRVA icon

Riverbridge Partners’s Privia Health PRVA Stock Holding History

Riverbridge Partners’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.2M Sell
2,998,597
-919,351
-23% -$21.3M 2.15% 12
2026
Q1 		$80.6M Sell
3,917,948
-665,642
-15% -$15M 1.97% 14
2025
Q4 		$109M Sell
4,583,590
-50,277
-1% -$1.22M 2.04% 10
2025
Q3 		$115M Sell
4,633,867
-314,004
-6% -$6.76M 1.95% 15
2025
Q2 		$114M Sell
4,947,871
-569,799
-10% -$13.2M 1.83% 14
2025
Q1 		$124M Sell
5,517,670
-306,788
-5% -$7.13M 1.99% 14
2024
Q4 		$114M Buy
5,824,458
+958,418
+20% +$19M 1.55% 22
2024
Q3 		$88.6M Sell
4,866,040
-280,177
-5% -$5.35M 1.18% 33
2024
Q2 		$89.4M Sell
5,146,217
-253,445
-5% -$4.49M 1.22% 27
2024
Q1 		$106M Buy
5,399,662
+804,304
+18% +$17M 1.29% 27
2023
Q4 		$106M Buy
4,595,358
+348,328
+8% +$7.8M 1.32% 24
2023
Q3 		$97.7M Sell
4,247,030
-97,012
-2% -$2.47M 1.33% 27
2023
Q2 		$113M Buy
4,344,042
+2,084,802
+92% +$55.1M 1.43% 23
2023
Q1 		$62.4M Buy
2,259,240
+325,767
+17% +$8.6M 0.87% 43
2022
Q4 		$43.9M Sell
1,933,473
-48,617
-2% -$1.35M 0.66% 55
2022
Q3 		$67.5M Sell
1,982,090
-9,439
-0.5% -$349K 1% 34
2022
Q2 		$58M Sell
1,991,529
-58,428
-3% -$1.49M 0.93% 39
2022
Q1 		$54.8M Buy
2,049,957
+261,365
+15% +$6.17M 0.62% 58
2021
Q4 		$46.3M Buy
+1,788,592
New +$44.6M 0.46% 71

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Riverbridge Partners's PRVA Position: Q2 2026 in Review

Riverbridge Partners reduced its Privia Health (PRVA) stake by 23% in Q2 2026, selling an estimated $21.3M and leaving 2,998,597 shares worth $77.2M. The position accounts for 2.15% of the portfolio, ranked #12.

Riverbridge Partners first reported a position in PRVA in Q4 2021 and has held it in 19 quarters since. The position peaked at $124M in Q1 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Riverbridge Partners held 2,998,597 shares of Privia Health worth $77.2M as of Q2 2026.
  • Riverbridge Partners sold 919,351 Privia Health shares in Q2 2026, an estimated $21.3M.
  • Privia Health made up 2.15% of Riverbridge Partners's portfolio in Q2 2026, its #12 holding.
  • Riverbridge Partners first reported a position in Privia Health in Q4 2021 and has held it in 19 quarters since.
  • Riverbridge Partners's Privia Health position peaked at $124M in Q1 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Riverbridge Partners's 13F filing for Q2 2026, filed 13 Jul 2026.